Skip to content
Full Committee Hearing

From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation

Date:
Time: 09:30am
Location: SH-216
Check back for live video of this hearing.

Witnesses

  • Annie Kennedy

    Chief Mission Officer
    EveryLife Foundation for Rare Diseases
    Washington, DC
  • Dr. Jeremy Schmahmann MD

    Director
    Massachusetts General Hospital Ataxia Center
    Boston, MA
  • Bradley Campbell

    President & CEO
    Amicus Therapeutics
    Princeton, NJ
  • Dr. Cara O'Neill MD, FAAP

    Chief Science Officer, Co-Founder
    Cure Sanfilippo Foundation
    Columbia, SC